www.fdanews.com/articles/205516-hagars-gwave-glucose-monitor-designated-an-fda-breakthrough-device
Hagar’s GWave Glucose Monitor Designated an FDA Breakthrough Device
November 29, 2021
The FDA has designated Hagar’s GWave noninvasive continuous glucose monitoring system a breakthrough device.
The GWave device is one-third the size of a smartphone and involves less radiofrequency exposure for users than a smartphone, the Israel-based company said.
The device uses radiofrequency waves to measure glucose levels in the blood without the need for a blood sample.